| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 145.28B | 144.57B | 140.19B | 140.86B | 136.85B | 121.14B |
| Gross Profit | 19.86B | 19.30B | 17.66B | 17.11B | 16.47B | 14.46B |
| EBITDA | 20.00B | 19.77B | 18.74B | 18.14B | 16.89B | 14.59B |
| Net Income | 10.10B | 9.80B | 9.74B | 8.93B | 8.58B | 6.75B |
Balance Sheet | ||||||
| Total Assets | 191.08B | 192.09B | 191.36B | 177.44B | 170.92B | 157.92B |
| Cash, Cash Equivalents and Short-Term Investments | 37.06B | 41.41B | 41.20B | 37.24B | 26.55B | 25.89B |
| Total Debt | 28.08B | 28.97B | 31.11B | 33.50B | 34.28B | 29.33B |
| Total Liabilities | 58.22B | 59.93B | 63.41B | 61.35B | 62.40B | 57.06B |
| Stockholders Equity | 130.79B | 130.05B | 125.93B | 114.17B | 106.66B | 99.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.36B | 10.43B | 10.48B | 1.89B | 887.00M |
| Operating Cash Flow | 0.00 | 16.27B | 14.51B | 16.50B | 12.24B | 11.38B |
| Investing Cash Flow | 0.00 | -10.42B | -4.07B | -6.09B | -11.01B | -11.32B |
| Financing Cash Flow | 0.00 | -9.12B | -6.66B | -3.60B | 2.67B | -39.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥171.01B | 12.93 | ― | 2.22% | 1.92% | -6.02% | |
74 Outperform | ¥160.60B | 9.98 | ― | 3.65% | 7.73% | -19.90% | |
68 Neutral | ¥983.37B | 10.15 | 9.97% | 3.54% | 12.46% | -3.12% | |
66 Neutral | ¥319.23B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
66 Neutral | ¥169.00B | 12.74 | ― | 1.84% | 10.32% | 42.14% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥922.78B | 310.63 | ― | 2.99% | 4.96% | 1.67% |